Tower Research Capital (TRC)’s Aterian ATER Stock Holding History
Bought
Maintained
Sold
Other funds holding ATER
BCM
XT
Tower Research Capital (TRC)'s ATER Position: Q2 2026 in Review
Tower Research Capital (TRC) increased its Aterian (ATER) stake by 159% in Q2 2026, buying an estimated $2.42K and bringing the position to 3,795 shares worth $5.01K. The position accounts for ﹤0.01% of the portfolio, ranked #4317.
Tower Research Capital (TRC) first reported a position in ATER in Q3 2019 and has held it in 28 quarters since. The position peaked at $93K in Q1 2021. 24 funds tracked by Wall St. Rank hold ATER as of Q2 2026.
- Tower Research Capital (TRC) held 3,795 shares of Aterian worth $5.01K as of Q2 2026.
- Tower Research Capital (TRC) bought 2,329 Aterian shares in Q2 2026, an estimated $2.42K.
- Aterian made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4317 holding.
- Tower Research Capital (TRC) first reported a position in Aterian in Q3 2019 and has held it in 28 quarters since.
- Tower Research Capital (TRC)'s Aterian position peaked at $93K in Q1 2021.
- 24 funds tracked by Wall St. Rank held Aterian as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.